Distillate Capital Partners LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1741001
CHICAGO, IL
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,503,558
+$429,234 QoQ
Shares Held
36,090
+26.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#204
of 1,322 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Distillate Capital Partners LLC holds $69,042,550 across 4 Biotechnology names. REGN ranks #1 (32.6% of the industry book) .
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,503,558 | 36,090 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,074,324 | 28,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,904,126 | 28,378 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,866,964 | 37,112 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,691,075 | 27,983 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $19,955,412 | 31,464 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,894,998 | 32,141 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $12,325 | 15 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,100 | 14 | Shares | Sole | 2023-02-15 | |
| 2022-06-30 | $7,380,258 | 12,485 | Shares | Sole | 2022-08-03 | |
| 2021-12-31 | $5,655,893 | 8,956 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,175,742 | 6,900 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $3,864,538 | 6,919 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,675,133 | 5,654 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,518,897 | 3,144 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||